PatternsRadar
Sign in

IPCALABIPCA Laboratories Limited

NSE
1,843.80INR-16.20 (-0.87%)Close · 20 Nov 2026
5 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹46,778 CrMarket cap
33.4P/E (TTM)
69.2%Delivery

Filings & corporate actions

77 results filed
CSV
Next results · Q3 FY27
Expected 13 Feb 2027 – 14 Feb 2027
Estimate: filed 44–45 days after quarter end, last 5 times
Dividend
₹6.00 per share · last 7 Aug 2026
2026
  • 5 NovresultsResults · Q2 FY27 · consolidated and standalone-0.4%NSE
  • 13 OctshareholdingShareholding · 30 Sept 2026+1.0%NSE
  • 13 AugresultsResults · Q1 FY27 · consolidated and standalone-3.5%NSE
  • 7 AugdividendDividend · ₹6.00 per share+0.1%
  • 17 JulshareholdingShareholding · 30 Jun 2026+0.6%NSE
  • 29 MayresultsResults · Q4 FY26 · consolidated and standalone-2.2%NSE
  • 8 AprshareholdingShareholding · 31 Mar 2026+0.2%NSE
  • 13 FebresultsResults · Q3 FY26 · consolidated and standalone+0.7%NSE
  • 14 JanshareholdingShareholding · 31 Dec 2025+0.6%NSE

Reaction to results · all yearsrose on day 0 in 40 of 77 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY275 Nov 2026-0.4%-3.4%—0.9×
Q1 FY2713 Aug 2026-3.5%+6.4%+9.6%1.4×
Q4 FY2629 May 2026-2.2%+8.2%+11.6%0.8×
Q3 FY2613 Feb 2026+0.7%-0.8%+5.4%1.2×
Q2 FY2613 Nov 2025+13.6%+10.9%+12.6%29.2×
Q1 FY2611 Aug 2025+3.0%+2.5%-1.8%1.4×
Q4 FY2529 May 2025-3.1%-6.7%-9.4%1.6×
Q3 FY2513 Feb 2025-1.8%-3.1%-9.6%2.8×
Q2 FY2514 Nov 2024+2.0%+1.9%+1.4%1.1×
Q1 FY2513 Aug 2024-3.4%+0.4%+4.3%2.2×
Q4 FY2429 May 2024-3.4%-10.2%-12.7%1.9×
Q3 FY2414 Feb 2024-0.2%+6.6%+2.5%1.4×
Q2 FY2410 Nov 2023-1.7%+1.0%+3.9%0.1×
Q1 FY2410 Aug 2023+0.7%-1.5%-0.1%1.9×
Q4 FY2329 May 2023-0.2%+8.6%+6.8%1.5×
Q3 FY2314 Feb 2023-0.7%-3.4%-8.0%1.6×
Q2 FY2311 Nov 2022+0.2%+0.1%-0.7%1.1×
Q1 FY2310 Aug 2022+2.5%-7.2%-11.7%1.3×
Q4 FY2225 May 2022-1.8%-6.9%-7.0%2.1×
Q3 FY2214 Feb 2022+2.5%-0.3%+3.7%3.0×
Q2 FY2213 Nov 2021-0.9%-7.3%-8.5%1.9×
Q1 FY225 Aug 2021+1.7%+11.7%+17.1%1.7×
Q4 FY2128 May 2021+2.1%+0.7%-0.6%1.6×
Q3 FY214 Feb 2021-3.5%-5.2%-3.9%1.0×
Q2 FY217 Nov 2020-3.2%-10.0%-3.5%2.9×
Q1 FY2110 Aug 2020-4.5%-4.5%-6.1%3.3×
Q4 FY2017 Jun 2020-2.0%+3.6%+3.4%1.0×
Q3 FY2013 Feb 2020+7.2%+9.9%-1.6%3.8×
Q2 FY208 Nov 2019+0.6%+9.1%+2.8%2.9×
Q1 FY2014 Aug 2019+0.5%+2.7%+1.3%0.3×
Q4 FY1930 May 2019+0.6%+1.1%-1.2%0.7×
Q3 FY1919 Feb 2019-0.7%-0.2%+15.3%0.7×
Q2 FY1927 Nov 2018+0.1%+1.3%+0.3%0.8×
Q1 FY1924 Aug 2018+2.0%+2.9%-6.0%1.1×
Q4 FY1826 Jun 2018+1.0%+7.4%+13.3%1.3×
Q3 FY1828 Feb 20180.0%-0.8%-1.2%0.3×
Q2 FY1822 Nov 2017+0.4%+0.7%+11.4%0.3×
Q1 FY1821 Aug 2017-0.2%+1.6%+20.4%1.7×
Q4 FY1720 Jun 2017+0.2%+1.6%+1.8%2.4×
Q3 FY1717 Feb 2017+3.8%+4.6%+4.9%3.1×
Q2 FY1715 Nov 2016-3.8%-3.0%-3.9%1.2×
Q1 FY1720 Sept 20160.0%+1.3%+3.8%0.5×
Q4 FY1631 May 2016+0.4%+0.8%+14.0%1.3×
Q3 FY169 Feb 2016+0.7%-6.5%-15.5%2.4×
Q2 FY162 Nov 2015-2.3%-7.1%-0.3%0.9×
Q1 FY163 Aug 2015+0.6%+5.3%+9.0%0.9×
Q4 FY153 Jun 2015-3.0%-1.7%+7.9%1.3×
Q3 FY159 Feb 2015+1.9%+9.7%+16.9%2.4×
Q2 FY1519 Nov 2014-0.4%+0.7%+4.8%0.2×
Q1 FY1514 Aug 2014-0.1%+3.7%+12.0%0.2×
Q4 FY1431 May 2014+0.1%+2.4%+11.3%1.2×
Q3 FY1429 Jan 2014+2.2%+2.6%+11.3%3.6×
Q2 FY146 Nov 2013+1.9%-0.7%-5.1%0.9×
Q1 FY1431 Jul 2013-0.2%-3.5%-3.1%0.7×
Q4 FY1311 Jun 2013+4.8%+12.2%+11.0%6.8×
Q3 FY1330 Jan 2013-1.1%-0.2%+1.4%2.6×
Q2 FY1325 Oct 2012-0.5%+1.5%-3.8%1.7×
Q1 FY1331 Jul 2012+0.6%+4.4%+8.6%1.2×
Q4 FY122 Jun 2012-1.0%+1.5%+5.0%0.2×
Q3 FY1231 Jan 2012+5.5%+13.6%+21.6%5.7×
Q2 FY1231 Oct 2011+5.6%+11.6%+7.1%2.7×
Q1 FY1228 Jul 2011-3.3%-4.2%-9.9%8.6×
Q3 FY1125 Jan 2011-2.2%-8.1%-10.6%4.0×
Q2 FY1122 Oct 2010+0.1%+9.2%+11.3%2.5×
Q1 FY1129 Jul 2010-2.1%+0.5%+4.0%2.5×
Q3 FY1021 Jan 2010-0.3%-4.4%-5.4%1.3×
Q2 FY1027 Oct 2009+2.0%+7.7%+11.2%2.5×
Q1 FY1030 Jul 2009+5.1%+6.7%+20.3%5.4×
Q4 FY0928 May 2009-4.2%+8.4%+0.6%3.8×
Q3 FY0922 Jan 2009-5.0%-0.8%-7.1%14.0×
Q2 FY0931 Oct 2008+8.3%+11.5%-8.8%3.5×
Q1 FY0925 Jul 2008+0.1%+0.7%+5.7%0.4×
Q4 FY0829 May 2008+1.4%-0.4%+0.4%1.3×
Q3 FY0819 Jan 2008-1.5%-6.5%-15.5%2.1×
Q2 FY0829 Oct 2007+0.6%+10.5%-0.7%1.6×
Q1 FY0820 Jul 2007+0.7%-0.8%-3.7%1.3×
Q4 FY0725 May 2007+0.3%+1.5%+16.3%2.9×
Average+0.3%+1.5%+2.4%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+13.8%
Profit YoY+32.8%
Interest cost YoY-18.5%
Revenue QoQ+4.4%
Profit QoQ-6.7%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+10.8%+16.2%+15.4%+13.2%+12.5%—
Profit+45.6%+41.6%+22.8%+7.3%+5.9%—

Key data

Open1,855.20
Day range1,825.10 – 1,879.00
52-week range1,361.70 – 2,038.00
From 52w high-9.5%
RSI (14)38.4
ATR (14)60.81
Volume2.83L
Avg volume (20D)2.64L
Rel volume1.07×
Volatility (1Y)27.0%
Turnover₹52.0Cr
Traded value (NSE)₹52.0Cr
VWAP1,839.95
SMA 50 / 2001,930.52 / 1,706.48
Price band20%

Delivery percentage

Latest · 20 Nov 202669.2%
20-day avg57.1%
1-year avg50.4%
Percentile (own history)80th
Range11.2–98.6%
Sessions3,629

Over the last 20 sessions IPCALAB settled 57.1% of its traded quantity, which is above average for an NSE equity. Its one-year average is 50.4%, so recent sessions are running 6.7 points higher than usual. The latest session ranks higher than 80% of the 3,629 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.33%
Dividend, trailing 12M₹6.00
Paid every year for10+ yr
Shareholders90.5K · +10.3% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy1,816 days ago

Performance returns

1D1W1M3M6M1Y
Price-0.87%-2.13%-3.14%-2.96%+12.63%+24.61%

Valuation

Market cap₹46,778 Cr
Market cap (NSE)₹46,778 Cr
Free-float cap₹25,859 Cr
P/E (TTM)33.4
P/E (NSE)31.8
EPS (TTM)55.28
P/B5.4
Net margin (TTM)13.4%
Other income / PBT8.3%
ROE17.4%
Debt / equity0.06
Shares outstanding25.37Cr
Listed8 Feb 1995

Ownership

Promoter44.72%
Promoter Δ QoQ0.00 pp
Public55.28%
FII11.53%
DII36.59%
Pledged0.00%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)2,392.52,388.52,788.12,909.9
YoY chg+6.6%+6.3%+20.8%+13.8%
Net profit (₹ Cr)363.7306.7424.3389.3
YoY chg+31.6%+379.3%+82.2%+38.8%
Net margin15.2%12.8%15.2%13.4%
EPS12.8611.7915.8414.79

Shareholding over time

By quarter

30 Sept 2026 · promoter 44.72% · public 55.28%
30 Sept 2021: promoter 46.29%31 Dec 2021: promoter 46.29%31 Mar 2022: promoter 46.29%30 Jun 2022: promoter 46.29%30 Sept 2022: promoter 46.29%31 Dec 2022: promoter 46.29%31 Mar 2023: promoter 46.29%30 Jun 2023: promoter 46.29%30 Sept 2023: promoter 46.29%31 Dec 2023: promoter 46.29%31 Mar 2024: promoter 46.30%30 Jun 2024: promoter 46.30%30 Sept 2024: promoter 46.30%31 Dec 2024: promoter 44.72%31 Mar 2025: promoter 44.72%30 Jun 2025: promoter 44.72%30 Sept 2025: promoter 44.72%31 Dec 2025: promoter 44.72%31 Mar 2026: promoter 44.72%30 Jun 2026: promoter 44.72%30 Sept 2026: promoter 44.72%
2021-092026-09
  • Promoter
  • Public and others
Promoter
44.72%
Public
55.28%
Promoter change
0.00 pp
Filed
13 Oct 2026
FII
11.53%
DII
36.59%
Promoter pledged
0.00%

Who the public is

Mutual funds
31.07%

-0.08 pp QoQ

Insurance
4.76%

-0.48 pp QoQ

FPI
11.52%

+0.80 pp QoQ

Retail ≤ ₹2L
5.72%

-0.04 pp QoQ

HNI > ₹2L
0.00%

0.00 pp QoQ

NRI
0.37%

0.00 pp QoQ

Bodies corporate
0.38%

+0.04 pp QoQ

Shareholders
90,514

+10.3% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
Kaygee Investments Private LimitedPromoter · Corporate25.49%
HDFC MUTUAL FUNDMutual fund9.51%
Kaygee Laboratories Private LimitedPromoter · Corporate6.61%
KOTAK MAHINDRA MUTUAL FUNDMutual fund6.34%
Chandurkar Investments Private LimitedPromoter · Corporate5.50%
DSP MUTUAL FUNDMutual fund4.12%
SBI LIFE INSURANCE CO. LTDInsurance3.53%
NIPPON INDIA MUTUAL FUNDMutual fund2.72%
Premchand GodhaPromoter · Individual2.29%
AXIS MUTUAL FUNDMutual fund2.04%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 7 Feb 2012 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹6.00₹6.00
FY2025-261₹2.00₹2.00
FY2024-252₹4.00₹4.00
FY2023-241₹2.00₹2.00
FY2022-231₹4.00₹4.00
FY2021-221₹8.00₹4.00
FY2020-211₹8.00₹4.00
FY2019-202₹8.00₹4.00
FY2018-191₹1.00₹0.50
FY2017-181₹1.00₹0.50
FY2015-161₹1.00₹0.50
FY2014-151₹2.50₹1.25
FY2013-142₹4.50₹2.25
FY2012-131₹1.20₹0.60
FY2011-121₹1.00₹0.50
Ex-dateRecord dateDeclaredAdjusted
7 Aug 2026—₹6.00₹6.00
5 Aug 2025—₹2.00₹2.00
27 Nov 2024—₹2.00₹2.00
6 Aug 2024—₹2.00₹2.00
22 Nov 2023—₹2.00₹2.00
22 Nov 2022—₹4.00₹4.00
22 Nov 2021—₹8.00₹4.00
13 Nov 2020—₹8.00₹4.00
18 Feb 2020—₹5.00₹2.50
6 Aug 2019—₹3.00₹1.50
2 Aug 2018—₹1.00₹0.50
27 Jul 2017—₹1.00₹0.50
22 Jul 2015—₹1.00₹0.50
18 Jul 2014—₹2.50₹1.25
31 Oct 2013—₹2.50₹1.25
19 Jul 2013—₹2.00₹1.00
20 Jul 2012—₹1.20₹0.60
7 Feb 2012—₹1.00₹0.50

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Book closures & record dates

Loading…

NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
2.7 years ago
Disclosures on record
57
40 open-market of the newest 57
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
18 Feb 2026MANISH KUMAR JAINOtherSell3.0K₹44.5L1,482.2223.3K → 20.3K0.01%-0.00 pp7(2)told 17 Feb 2026
25 Aug 2025Pawan KothariEmployeeSell2.2K₹31.4L1,413.022.2K → —0.00%7(2)told 25 Aug 2025
12 Mar 2024Paschim Chemicals Private LimitedPromoterBuy35.0K₹4.2Cr1,200.971.01Cr → 1.02Cr4.01%+0.01 pp7(2)told 11 Mar 2024
20 Nov 2023Mr. Ajit Kumar JainAADPJ2602AOtherSell20.0K₹2.2Cr1,081.8562.0K → 42.0K0.02%-0.01 pp7(2)told 20 Nov 2023
19 Sept 2022E J BABUOtherSell2.0K₹17.5L874.3916.0K → 14.0K0.01%-0.00 pp7(2)told 16 Sept 2022
21 Mar 2022Ajit Kumar JainDirectorSell20.0K₹2.1Cr1,026.8282.0K → 62.0K0.02%-0.01 pp7(2)told 21 Mar 2022
26 Aug 2021Kavita SehwaniEmployeeSell450₹11.0L2,441.1621.9K → 21.4K0.02%-0.00 pp7(2)told 25 Aug 2021
23 Aug 2021Pabitra Kumar BhattacharyyaEmployeeSell4.0K₹1.0Cr2,510.005.0K → 1.0K0.00%0.00 pp7(2)told 23 Aug 2021
19 Aug 2021Ajit Kumar JainDirectorSell10.0K₹2.4Cr2,421.9051.0K → 41.0K0.03%-0.01 pp7(2)told 18 Aug 2021
13 Aug 2021Dr. Anil Kumar PareekEmployeeSell1.6K₹38.1L2,383.3019.6K → 18.0K0.01%-0.00 pp7(2)told 13 Aug 2021
30 Mar 2021Dr. Goutam MuhuriEmployeeBuy1.0K₹18.9L1,887.35— → 1.0K0.00%7(2)told 29 Mar 2021
25 Feb 2021Harish KamathEmployeeSell7.0K₹1.3Cr1,819.397.1K → 1000.00%0.00 pp7(2)told 23 Feb 2021
14 Dec 2020Dr. Ashok KumarEmployeeSell1.0K₹22.5L2,250.0040.0K → 39.0K0.03%-0.00 pp7(2)told 14 Dec 2020
25 Nov 2020Dr. Ashok KumarEmployeeSell500₹11.0L2,200.0040.5K → 40.0K0.03%-0.00 pp7(2)told 24 Nov 2020
30 Sept 2020E J BABUEmployeeSell2.7K₹55.6L2,060.1310.7K → 8.0K0.00%0.00 pp7(2)told 30 Sept 2020
30 Sept 2020Prakash NayakEmployeeSell2.0K₹41.9L2,094.387.0K → 5.0K0.00%0.00 pp7(2)told 30 Sept 2020
18 Sept 2020Prakash NayakEmployeeSell1.0K₹21.6L2,164.408.0K → 7.0K0.01%-0.00 pp7(2)told 17 Sept 2020
18 Sept 2020Ajit Kumar JainDirectorSell4.2K₹90.9L2,164.9755.2K → 51.0K0.04%-0.00 pp7(2)told 17 Sept 2020
18 Sept 2020Dr. Ashok KumarEmployeeSell1.0K₹21.9L2,187.3341.5K → 40.5K0.03%-0.00 pp7(2)told 17 Sept 2020
16 Sept 2020Prakash NayakEmployeeSell1.0K₹21.2L2,122.009.0K → 8.0K0.01%-0.00 pp7(2)told 16 Sept 2020
16 Sept 2020Prakash KothariEmployeeSell700₹14.4L2,063.022.1K → 1.4K0.01%-0.00 pp7(2)told 15 Sept 2020
16 Sept 2020Dr. Ashok KumarEmployeeSell2.0K₹42.3L2,112.7643.5K → 41.5K0.03%-0.00 pp7(2)told 15 Sept 2020
9 Sept 2020Prakash NayakEmployeeSell1.0K₹20.4L2,042.1810.0K → 9.0K0.01%-0.00 pp7(2)told 8 Sept 2020
7 Sept 2020Prakash NayakEmployeeSell1.0K₹20.4L2,038.2911.0K → 10.0K0.01%-0.00 pp7(2)told 4 Sept 2020
26 Aug 2020Ajit Kumar JainDirectorSell12.0K₹2.5Cr2,047.2267.2K → 55.2K0.04%-0.01 pp7(2)told 26 Aug 2020
22 Nov 2019Kavita SehwaniEmployeeSell1.5K₹17.1L1,128.2823.8K → 22.3K0.02%-0.00 pp7(2)told 20 Nov 2019
28 Jun 2019Muralikrishnan A. P. SarmaEmployeeSell9.7K₹89.6L925.9319.0K → 9.3K0.01%-0.01 pp7(2)told 27 Jun 2019
18 Sept 2017Dr. Ashok KumarEmployeeSell5.0K₹24.4L487.2244.5K → 39.5K0.03%-0.00 pp7(2)told 15 Sept 2017
5 Jun 2017Dr. Ashok KumarEmployeeSell4.0K₹19.9L498.5848.5K → 44.5K0.04%-0.00 pp7(2)told 2 Jun 2017
18 Nov 2016Pranay GodhaPromoterBuy15.0K₹80.5L536.948.10L → 8.25L0.65%+0.01 pp7(2)told 17 Nov 2016
21 Oct 2016TORIES PRIVATE LIMITEDPromoterBuy50.0K₹3.1Cr621.6782.71L → 83.21L6.59%+0.04 pp7(2)told 20 Oct 2016
4 Oct 2016Pranay GodhaPromoterBuy82.0K₹5.0Cr606.417.28L → 8.10L0.64%+0.06 pp7(2)told 4 Oct 2016
27 Sept 2016Pranay GodhaPromoterBuy12.5K₹74.0L592.687.16L → 7.28L0.58%+0.01 pp7(2)told 26 Sept 2016
27 Sept 2016PRASHANT GODHAPromoterBuy27.5K₹1.7Cr600.137.32L → 7.59L0.60%+0.02 pp7(2)told 26 Sept 2016
18 Jul 2016Pranay GodhaDirectorBuy7.0K₹33.0L471.477.09L → 7.16L0.57%+0.01 pp7(2)told 16 Jul 2016
15 Jul 2016Pranay GodhaDirectorBuy1.00L₹4.6Cr462.386.09L → 7.09L0.56%+0.08 pp7(2)told 14 Jul 2016
27 Jun 2016Dev Parkash YadavaDirectorBuy5.0K₹23.0L459.319.6K → 14.6K0.01%+0.00 pp7(2)told 27 Jun 2016
22 Jun 2016Dev Parkash YadavaDirectorBuy5.0K₹24.3L485.444.6K → 9.6K0.01%+0.00 pp7(2)told 21 Jun 2016
7 Jun 2016Neetu Godha (wife of Pranay Godha)RelativeBuy2.0K₹8.3L412.89— → 2.0K0.00%7(2)told 6 Jun 2016
7 Jun 2016Pranay GodhaDirectorBuy2.1K₹8.7L417.446.07L → 6.09L0.48%+0.00 pp7(2)told 6 Jun 2016

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Bulk & block deals · 14 Nov 2022

CSV
12 of 40 deals
By year
DateDealClientQuantityPriceValue
14 Nov 2022Sell · blockISHARES CORE EMERGING MARKETS MAURITIUS CO1.59L867.55₹13.8Cr
14 Nov 2022Buy · blockISHARES CORE MSCI EMERGING MARKETS ETF1.59L867.55₹13.8Cr
3 Nov 2022Sell · blockISHARES CORE EMERGING MARKETS MAURITIUS CO1.59L927.15₹14.7Cr
3 Nov 2022Buy · blockISHARES CORE MSCI EMERGING MARKETS ETF1.59L927.15₹14.7Cr
3 Oct 2022Sell · blockISHARES CORE EMERGING MARKETS MAURITIUS CO1.71L915.00₹15.6Cr
3 Oct 2022Buy · blockISHARES CORE MSCI EMERGING MARKETS ETF1.71L915.00₹15.6Cr
3 Oct 2022Sell · blockISHARES INDIA SC MAURITIUS COMPANY25.1K915.00₹2.3Cr
3 Oct 2022Buy · blockISHARES MSCI INDIA SMALL-CAP ETF25.1K915.00₹2.3Cr
30 Nov 2021Buy · bulkINTEGRATED CORE STRATEGIES (ASIA) PTE. LTD.25.46L2,103.52₹535.7Cr
4 Oct 2021Sell · blockISHARES EMERGING MARKETS INDEX MAURITIUS CO70.1K2,423.60₹17.0Cr
4 Oct 2021Buy · blockISHARES MSCI EMERGING MARKETS ETF70.1K2,423.60₹17.0Cr
27 Nov 2020Sell · bulkINTEGRATED CORE STRATEGIES (ASIA) PTE. LTD.20.15L2,158.70₹435.0Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026

No surveillance measure applies to IPCALAB.

Price band: 20% · not in the F&O ban · 10.6% of the market-wide position limit used.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes · MWPL.

Every stock on this session →

Futures & options · 27 Feb 2025

CSV

Short buildup — price down as fresh positions opened — new shorts.

Futures OI
9.98L

₹136.7Cr

OI change
+1.92%
Basis
-0.19%
Rollover
0.0%
PCR (OI)
0.75
PCR (volume)
0.62
Front settle
1,368.80
Lot size
650

shares

Futures volume
1.3K

contracts

Futures trades
1,222
Futures value
₹115.2Cr
Sessions shown
250

Open interest is in shares (index units for an index), summed over every expiry; volume, trades and traded value too. Settle and lot size are the front future’s. Buildup compares the close’s direction with the change in futures OI across the contracts still open, so an expiring contract does not read as unwinding. Scan it with pattern is long_buildup.

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations2,052.92,033.02,092.62,354.92,245.42,246.72,308.92,556.52,392.52,388.52,788.12,909.9
Other income22.518.920.626.320.125.832.727.920.293.725.325.0
Total income2,075.32,051.92,113.22,381.22,265.52,272.52,341.52,584.42,412.72,482.22,813.42,935.0
Total expenses1,854.41,838.61,822.92,036.31,897.61,939.52,011.02,134.51,984.42,032.02,241.32,363.5
└ Finance costs33.429.424.122.616.821.518.519.617.620.211.912.6
└ Depreciation99.598.198.9100.498.5100.1100.1103.3107.6107.1110.8114.5
Profit before tax288.976.6290.4344.8367.9128.0330.5391.6446.0404.5572.1547.2
Tax expense66.273.791.499.490.662.296.1108.181.995.1149.3155.6
Net profit221.01.3199.1245.8276.464.0232.9280.5363.7306.7424.3389.3
EPS7.092.357.589.059.782.679.1911.1412.8611.7915.8414.79
Net margin10.77%0.07%9.52%10.44%12.31%2.85%10.09%10.97%15.20%12.84%15.22%13.38%
PBT margin14.07%3.77%13.88%14.64%16.39%5.70%14.31%15.32%18.64%16.93%20.52%18.80%
Tax rate22.93%96.20%31.48%28.82%24.62%48.61%29.07%27.60%18.37%23.50%26.09%28.44%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 5 Nov 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets8,626.411,383.811,101.311,423.811,760.612,262.712,370.213,132.9
Current assets5,189.35,716.25,535.65,674.45,967.06,251.96,373.66,923.9
└ Cash & equivalents1,257.9433.9208.9255.9167.2213.0437.1207.1
└ Other bank balances595.464.887.941.1177.150.9127.558.3
└ Current investments323.3435.3558.4606.2763.4991.2633.4845.5
└ Trade receivables989.01,760.01,686.51,813.61,873.82,077.12,014.32,395.1
└ Inventories1,743.42,452.02,471.32,518.22,560.42,515.92,731.02,937.8
Total equity5,915.37,560.87,727.08,117.78,388.38,865.89,524.110,173.7
└ Attributable to owners5,842.06,148.76,332.26,700.46,948.57,426.98,063.88,678.3
└ Non-controlling interest73.31,412.11,394.81,417.31,439.81,438.91,460.31,495.4
└ Share capital25.425.425.425.425.425.425.425.4
Borrowings1,457.51,953.01,387.51,156.51,301.71,205.2703.9626.3
└ Current805.81,249.6807.1699.3758.5805.0594.8558.9
└ Non-current651.8703.5580.4457.1543.2400.2109.167.4
Trade payables525.1795.1776.1906.1846.2821.6940.31,074.4
Current liabilities1,805.82,686.32,355.62,395.92,384.32,537.52,306.92,406.9
Total liabilities2,711.13,823.03,374.33,306.13,372.33,396.82,846.12,959.2
Net debt(719.0)1,018.9532.3253.2194.1(49.8)(494.1)(484.7)
Debt / equity0.250.260.180.140.160.140.070.06
Current ratio2.872.132.352.372.502.462.762.88

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow805.8242.9944.7739.61,321.3780.11,142.0573.3
└ Capex(494.5)(211.9)(411.3)(345.0)(775.5)(461.5)(652.3)(442.8)
Free cash flow311.330.9533.4394.6545.8318.6489.7130.5
Investing cash flow(725.0)(1,164.7)(1,291.8)(300.8)(869.5)(298.2)(246.8)(341.2)
Financing cash flow507.2131.2(552.6)(336.3)(283.0)(210.6)(753.5)(252.1)
└ Dividends paid(101.5)0.0(50.7)(50.7)(101.5)(52.7)(52.4)(153.9)
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash588.1(790.7)(899.7)102.5168.8271.3141.7(20.0)

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

IPCALAB at a glance

  • IPCALAB closed at ₹1,843.8 on 20 Nov 2026, -0.87% on the day, +24.6% over one year, 9.5% below its 52-week high of ₹2,038.
  • Delivery was 69.2% of traded quantity on 20 Nov 2026, the 80th percentile of its own 3,629 sessions with a reading (20-session average 57.1%, 1-year average 50.4%).
  • Market capitalisation is ₹46,778 crore at a trailing P/E of 33.4 (trailing EPS ₹55.28).
  • Q2 FY27 results (consolidated, filed 5 Nov 2026): revenue ₹2,910 crore (+13.8% year on year), net profit ₹389 crore (+38.8%); the price moved -0.4% on the first session after.
  • Promoters held 44.72% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 13 Feb 2027 and 14 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE571A01038
SeriesEQ
Listed8 Feb 1995
NSE market cap · 17 Nov 2026₹46,540 Cr
Free-float market cap (NSE)₹25,417 Cr
Shares outstanding (NSE)25.37Cr
History from2 Jan 1995
Sessions7,868
Turnover rank#435

Sector history

  1. to 16 Aug 2026Index industry · Healthcare
  2. from 16 Aug 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

NSE’s own classification, by the snapshot it changed on.

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.